Niche-Selective Inhibition of Pathogenic Th17 Cells by Targeting Metabolic Redundancy is a research paper published in Cell (2020). On theSindex it has a DataRank of 0. It has been cited 115 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: P30CA016087
National Institutes of Health
Grant: R01AI121436
National Multiple Sclerosis Society
Grant: FG 2089-A-1
NIAID NIH HHS
Grant: T32 AI100853
NIGMS NIH HHS
Grant: R01 GM132491
NIAID NIH HHS
Grant: R01 AI080885
NCI NIH HHS
Grant: R01 CA214948
Pfizer Pharmaceuticals
Albert Einstein College of Medicine, Yeshiva University
Howard Hughes Medical Institute
FWCI
5.16
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals